TherapeuticsMD, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • March 4th, 2021 • TherapeuticsMD, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2021 Company Industry JurisdictionTherapeuticsMD, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows: